MedTrace Logo

Study of Colchicine to Prevent the Postpericardiotomy Syndrome

NCT00128427 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2010-06-15

No results posted yet for this study

Summary

The purpose of the study is to determine whether colchicine is safe and effective in the prevention of the postpericardiotomy syndrome.

Conditions

  • Postpericardiotomy Syndrome

Interventions

DRUG

Colchicine (for 1 month)

Sponsors & Collaborators

  • Azienda Sanitaria Locale 3, Torino

    lead OTHER

Principal Investigators

  • Rita TRINCHERO, MD · Cardiology Department. Maria Vittoria Hospital. ASL 3. Torino.

  • Massimo IMAZIO, MD · Cardiology Department. Maria Vittoria Hospital. ASL 3. Torino.

  • Massimo IMAZIO, MD · Cardiology Department. Maria Vittoria Hospital. ASL 3. Torino.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00128427 on ClinicalTrials.gov